Which of the following is a standard of safe administration?

Prepare for the Durham College Consolidation Exam. Study with flashcards and multiple choice questions, each question includes hints and explanations. Ace your test!

Multiple Choice

Which of the following is a standard of safe administration?

Explanation:
The main idea here is safety in IV administration: you must protect blood products from potential interactions by not introducing other medications through the same administration pathway. Blood products have strict compatibility and stability requirements, and adding meds to the line that already contains a blood product can cause adverse reactions, precipitation, or damage to the product. So the standard practice is to use a separate line for medications or ensure a clearly established protocol for compatibility, rather than mixing them in the same administration set. This is why the chosen option is the best. It aligns with safe IV practice by preventing any potential incompatibilities or reactions that could arise from combining a medication with a blood product. In contrast, the other statements imply universal mixing, bypassing compatibility checks, or indiscriminate drug addition, all of which pose clear safety risks and are not acceptable in proper administration protocols.

The main idea here is safety in IV administration: you must protect blood products from potential interactions by not introducing other medications through the same administration pathway. Blood products have strict compatibility and stability requirements, and adding meds to the line that already contains a blood product can cause adverse reactions, precipitation, or damage to the product. So the standard practice is to use a separate line for medications or ensure a clearly established protocol for compatibility, rather than mixing them in the same administration set.

This is why the chosen option is the best. It aligns with safe IV practice by preventing any potential incompatibilities or reactions that could arise from combining a medication with a blood product. In contrast, the other statements imply universal mixing, bypassing compatibility checks, or indiscriminate drug addition, all of which pose clear safety risks and are not acceptable in proper administration protocols.

Subscribe

Get the latest from Passetra

You can unsubscribe at any time. Read our privacy policy